A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations
Clinical trial NCT04083976 · COMPLETED
Trial details
- NCT number
- NCT04083976
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2023-12-04
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.